Filings For: Outlook Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Outlook Therapeutics, Inc. (OTLK) 8/18/2026 5:42:46 PM Micro View Financials 10-Q SEC 3Q 2026 ending: 6/30/2026 Rev: $8,700 -99.4% Assets $26,184,850 EPS -$0.15
Outlook Therapeutics, Inc. (OTLK) 8/14/2026 8:02:44 AM   View Financials Earnings SEC 3Q 2026 Rev $8,700 -99.4% Assets $26,184,850 EPS -$0.15 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 6/1/2026 5:01:53 PM   View Proxy SEC Y 2025
Outlook Therapeutics, Inc. (OTLK) 5/18/2026 6:04:39 AM   View Financials Earnings SEC 2Q 2026 Rev $127,439 Assets $21,892,406 EPS -$0.05 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/15/2026 4:45:17 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 3/31/2026 Rev: $127,439 Assets $21,892,406 EPS -$0.05
Outlook Therapeutics, Inc. (OTLK) 2/17/2026 5:14:49 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 12/31/2025 Assets $18,238,574 EPS -$0.38
Outlook Therapeutics, Inc. (OTLK) 2/17/2026 8:32:06 AM   View Financials Earnings SEC 1Q 2026 Rev ($1,207,833) Assets $18,238,574 EPS -$0.38 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 1/26/2026 5:02:01 PM   View Proxy SEC Y 2025
Outlook Therapeutics, Inc. (OTLK) 12/19/2025 5:12:11 PM Micro View Financials 10-K SEC Y 2025 ending: 9/30/2025 Rev: $1,413,535 Assets $18,584,183 EPS -$1.79
Outlook Therapeutics, Inc. (OTLK) 12/19/2025 8:32:41 AM   View Financials Earnings SEC Y 2025 Rev ($91,787) Assets $18,584,183 EPS -$0.19 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/14/2025 5:13:33 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 6/30/2025 Rev: $1,505,322 Assets $22,391,540 EPS -$0.55
Outlook Therapeutics, Inc. (OTLK) 8/14/2025 4:28:08 PM   View Financials Earnings SEC 3Q 2025 Rev $1,505,322 Assets $22,391,540 EPS -$0.55 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/15/2025 4:13:27 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 3/31/2025 Assets $19,075,125 EPS -$1.50
Outlook Therapeutics, Inc. (OTLK) 5/15/2025 4:07:08 PM   View Financials Earnings SEC 2Q 2025 Rev ($18,502) Assets $19,075,125 EPS -$1.50 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2025 5:12:31 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 12/31/2024 Rev: $48,881 -74.1% Assets $17,006,065 EPS $0.72
Outlook Therapeutics, Inc. (OTLK) 2/14/2025 8:15:41 AM   View Financials Earnings SEC 1Q 2025 Rev $48,881 -74.1% Assets $17,006,065 EPS $0.72 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/10/2025 4:18:32 PM   View Proxy SEC Y 2024
Outlook Therapeutics, Inc. (OTLK) 1/23/2025 5:16:26 PM Micro View Financials 10-K/A SEC Y 2024 ending: 9/30/2024 Assets $28,823,154 EPS -$4.06
Outlook Therapeutics, Inc. (OTLK) 12/27/2024 4:45:03 PM Micro View Financials 10-K SEC Y 2024 ending: 9/30/2024 Assets $28,823,154 EPS -$4.06
Outlook Therapeutics, Inc. (OTLK) 12/27/2024 8:16:19 AM   View Financials Earnings SEC Y 2024 Assets $28,823,154 EPS $0.76 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/14/2024 4:25:32 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 6/30/2024 Assets $47,091,727 EPS -$0.89
Outlook Therapeutics, Inc. (OTLK) 8/14/2024 7:49:38 AM   View Financials Earnings SEC 3Q 2024 Assets $47,091,727 EPS -$0.89 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 6/26/2024 7:25:52 AM   View Proxy SEC Y 2023
Outlook Therapeutics, Inc. (OTLK) 5/15/2024 5:29:25 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 3/31/2024 Assets $59,028,670 EPS -$8.01
Outlook Therapeutics, Inc. (OTLK) 5/15/2024 5:19:55 PM   View Financials Earnings SEC 2Q 2024 Rev ($3,084,035) Assets $59,028,670 EPS -$8.01 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2024 5:28:35 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 12/31/2023 Rev: $188,677 Assets $21,684,965 EPS -$0.86
Outlook Therapeutics, Inc. (OTLK) 2/14/2024 4:41:45 PM   View Financials Earnings SEC 1Q 2024 Rev $188,677 Assets $21,684,965 EPS -$0.86 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/8/2024 7:00:58 AM   View Proxy SEC Y 2023
Outlook Therapeutics, Inc. (OTLK) 1/24/2024 5:17:23 PM Micro View Financials 10-K/A SEC Y 2023 ending: 9/30/2023 Assets $32,300,601 EPS -$4.72
Outlook Therapeutics, Inc. (OTLK) 12/22/2023 5:15:48 PM Micro View Financials 10-K SEC Y 2023 ending: 9/30/2023 Assets $32,300,601 EPS -$4.72
Outlook Therapeutics, Inc. (OTLK) 12/22/2023 4:16:18 PM   View Financials Earnings SEC Y 2023 Assets $32,300,601 EPS -$0.99 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/14/2023 4:45:04 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 6/30/2023 Assets $44,447,174 EPS -$1.61
Outlook Therapeutics, Inc. (OTLK) 8/14/2023 4:22:55 PM   View Financials Earnings SEC 3Q 2023 Assets $44,447,174 EPS -$1.61 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/15/2023 5:10:56 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 3/31/2023 Rev: $187,794 Assets $54,024,028 EPS -$0.52
Outlook Therapeutics, Inc. (OTLK) 5/15/2023 4:37:45 PM   View Financials Earnings SEC 2Q 2023 Rev $187,794 Assets $54,024,028 EPS -$0.52 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/15/2023 8:16:14 AM   View Proxy SEC Y 2022
Outlook Therapeutics, Inc. (OTLK) 2/14/2023 4:57:43 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 12/31/2022 Assets $62,688,430 EPS -$0.08
Outlook Therapeutics, Inc. (OTLK) 2/14/2023 8:15:29 AM   View Financials Earnings SEC 1Q 2023 Rev ($2,448,591) Assets $62,688,430 EPS -$0.08 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 1/24/2023 4:16:11 PM Micro View Financials 10-K/A SEC Y 2022 ending: 9/30/2022 Assets $28,527,751 EPS -$0.31
Outlook Therapeutics, Inc. (OTLK) 12/29/2022 5:15:45 PM Micro View Financials 10-K SEC Y 2022 ending: 9/30/2022 Assets $28,527,751 EPS -$0.31
Outlook Therapeutics, Inc. (OTLK) 12/29/2022 9:18:11 AM   View Financials Earnings SEC Y 2022 Rev ($360,648) Assets $28,527,751 EPS -$0.06 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/10/2022 5:15:49 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 6/30/2022 Assets $38,587,727 EPS -$0.08
Outlook Therapeutics, Inc. (OTLK) 8/10/2022 8:31:29 AM   View Financials Earnings SEC 3Q 2022 Rev ($356,947) Assets $38,587,727 EPS -$0.08 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/13/2022 5:16:55 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 3/31/2022 Assets $67,686,293 EPS -$0.09
Outlook Therapeutics, Inc. (OTLK) 5/13/2022 4:27:01 PM   View Financials Earnings SEC 2Q 2022 Rev ($418,327) Assets $67,686,293 EPS -$0.09 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2022 6:25:15 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 12/31/2021 Assets $78,678,144 EPS -$0.08
Outlook Therapeutics, Inc. (OTLK) 2/14/2022 4:40:58 PM   View Financials Earnings SEC 1Q 2022 Rev ($351,534) Assets $78,678,144 EPS -$0.08 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 1/27/2022 4:35:18 PM   View Proxy SEC Y 2021
Outlook Therapeutics, Inc. (OTLK) 12/23/2021 7:23:50 AM Micro View Financials 10-K SEC Y 2021 ending: 9/30/2021 Assets $22,811,451 EPS -$0.35
Outlook Therapeutics, Inc. (OTLK) 12/22/2021 4:08:44 PM   View Financials Earnings SEC Y 2021 Rev ($269,182) Assets $22,811,451 EPS -$0.08 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/13/2021 5:13:23 PM Micro View Financials 10-Q SEC 3Q 2021 ending: 6/30/2021 Assets $32,882,068 EPS -$0.07
Outlook Therapeutics, Inc. (OTLK) 8/13/2021 4:41:06 PM   View Financials Earnings SEC 3Q 2021 Rev ($256,873) Assets $32,882,068 EPS -$0.07 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/14/2021 4:44:24 PM Micro View Financials 10-Q SEC 2Q 2021 ending: 3/31/2021 Assets $45,111,814 EPS -$0.09
Outlook Therapeutics, Inc. (OTLK) 5/14/2021 8:31:50 AM   View Financials Earnings SEC 2Q 2021 Rev ($250,409) Assets $45,111,814 EPS -$0.09 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/22/2021 8:56:14 AM   View Proxy SEC Y 2020
Outlook Therapeutics, Inc. (OTLK) 2/16/2021 5:21:38 PM Micro View Financials 10-Q SEC 1Q 2021 ending: 12/31/2020 Assets $12,517,983 EPS -$0.12
Outlook Therapeutics, Inc. (OTLK) 2/16/2021 5:13:31 PM   View Financials Earnings SEC 1Q 2021 Rev ($159,663) Assets $12,517,983 EPS -$0.12 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 12/28/2020 5:16:25 PM   View Financials Earnings SEC Y 2020 Rev ($19,031) Assets $19,732,551 EPS $0.02 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 12/23/2020 5:12:04 PM Micro View Financials 10-K SEC Y 2020 ending: 9/30/2020 Assets $19,732,551 EPS -$0.67
Outlook Therapeutics, Inc. (OTLK) 8/18/2020 4:16:36 PM   View Proxy SEC Y 2019
Outlook Therapeutics, Inc. (OTLK) 8/14/2020 4:55:17 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 6/30/2020 Assets $30,242,960 EPS -$0.03
Outlook Therapeutics, Inc. (OTLK) 8/14/2020 8:12:06 AM   View Financials Earnings SEC 3Q 2020 Rev ($443,624) Assets $30,242,960 EPS -$0.03 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 5/15/2020 5:06:17 PM Micro View Financials 10-Q SEC 2Q 2020 ending: 3/31/2020 Assets $13,169,855 EPS -$0.36
Outlook Therapeutics, Inc. (OTLK) 5/15/2020 5:04:11 PM   View Financials Earnings SEC 2Q 2020 Assets $13,169,855 EPS -$0.36 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2020 5:44:46 PM   View Proxy SEC Y 2019
Outlook Therapeutics, Inc. (OTLK) 2/14/2020 5:22:40 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 12/31/2019 Assets $10,423,095 EPS -$0.62
Outlook Therapeutics, Inc. (OTLK) 2/14/2020 4:27:42 PM   View Financials Earnings SEC 1Q 2020 Assets $10,423,095 EPS -$0.62 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 12/19/2019 4:19:19 PM   View Financials Earnings SEC Y 2019 Rev $5,853,537 +658.3% Assets $17,134,997 EPS -$0.24 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 12/19/2019 9:55:47 AM Micro View Financials 10-K SEC Y 2019 ending: 9/30/2019 Rev: $8,146,123 +163.8% Assets $17,134,997 EPS -$1.98
Outlook Therapeutics, Inc. (OTLK) 8/14/2019 5:58:48 PM   View Financials Earnings SEC 3Q 2019 Rev $583,848 -24.4% Assets $33,214,095 EPS -$0.20 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 8/14/2019 5:15:00 PM Micro View Financials 10-Q SEC 3Q 2019 ending: 6/30/2019 Rev: $583,848 -24.4% Assets $33,214,095 EPS -$0.20
Outlook Therapeutics, Inc. (OTLK) 8/1/2019 5:09:55 PM   View Proxy SEC Y 2018
Outlook Therapeutics, Inc. (OTLK) 5/15/2019 5:20:46 PM Micro View Financials 10-Q SEC 2Q 2019 ending: 3/31/2019 Rev: $641,140 -16.9% Assets $17,172,187 EPS -$0.98
Outlook Therapeutics, Inc. (OTLK) 5/15/2019 5:11:56 PM   View Financials Earnings SEC 2Q 2019 Rev $641,140 -16.9% Assets $17,172,187 EPS -$0.98 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2019 4:53:39 PM   View Financials Earnings SEC 1Q 2019 Rev $1,067,598 +38.3% Assets $18,709,699 EPS -$1.00 Export Earnings Model
Outlook Therapeutics, Inc. (OTLK) 2/14/2019 4:49:38 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 12/31/2018 Rev: $1,067,598 +38.3% Assets $18,709,699 EPS -$1.00
Outlook Therapeutics, Inc. (OTLK) 12/18/2018 4:51:40 PM Micro View Financials 10-K SEC Y 2018 ending: 9/30/2018 Rev: $3,087,560 -19.0% Assets $22,283,495 EPS -$1.22
Outlook Therapeutics, Inc. (OTLK) 12/18/2018 4:16:46 PM   View Financials Earnings SEC Y 2018 Rev $771,890 -73.4% Assets $22,283,495 EPS $0.02 Export Earnings Model
Oncobiologics, Inc. (OTLK) 8/17/2018 7:01:22 AM   View Proxy SEC Y 2017
Oncobiologics, Inc. (OTLK) 8/14/2018 5:16:02 PM Micro View Financials 10-Q SEC 3Q 2018 ending: 6/30/2018 Rev: $771,890 +154.6% Assets $34,086,042 EPS -$0.26
Oncobiologics, Inc. (OTLK) 8/14/2018 5:00:25 PM   View Financials Earnings SEC 3Q 2018 Rev $771,890 +154.6% Assets $34,086,042 EPS -$0.26 Export Earnings Model
Oncobiologics, Inc. (OTLK) 5/15/2018 5:30:39 PM Micro View Financials 10-Q SEC 2Q 2018 ending: 3/31/2018 Rev: $771,890 +154.6% Assets $27,786,656 EPS -$0.34
Oncobiologics, Inc. (OTLK) 5/15/2018 4:49:11 PM   View Financials Earnings SEC 2Q 2018 Rev $771,890 +154.6% Assets $27,786,656 EPS -$0.34 Export Earnings Model
Oncobiologics, Inc. (OTLK) 2/15/2018 6:02:14 AM   View Financials Earnings SEC 1Q 2018 Rev $771,890 +154.6% Assets $32,276,704 EPS -$0.71 Export Earnings Model
Oncobiologics, Inc. (OTLK) 2/14/2018 7:27:28 PM Micro View Financials 10-Q SEC 1Q 2018 ending: 12/31/2017 Rev: $771,890 +154.6% Assets $32,276,704 EPS -$0.71
Oncobiologics, Inc. (OTLK) 12/29/2017 4:26:45 PM Micro View Financials 10-K SEC Y 2017 ending: 9/30/2017 Rev: $3,811,519 +27.9% Assets $20,733,870 EPS -$1.80
Oncobiologics, Inc. (OTLK) 9/29/2017 4:10:28 PM   View Proxy SEC Y 2016
Oncobiologics, Inc. (OTLK) 8/14/2017 5:15:49 PM Micro View Financials 10-Q SEC 3Q 2017 ending: 6/30/2017 Rev: $303,140 -38.7% Assets $17,127,062 EPS -$0.22
Oncobiologics, Inc. (OTLK) 5/15/2017 6:05:32 PM Micro View Financials 10-Q SEC 2Q 2017 ending: 3/31/2017 Rev: $303,140 -69.5% Assets $17,460,310 EPS -$0.38
Oncobiologics, Inc. (OTLK) 2/14/2017 4:16:49 PM Micro View Financials 10-Q SEC 1Q 2017 ending: 12/31/2016 Rev: $303,140 -69.5% Assets $20,446,317 EPS -$0.82
Oncobiologics, Inc. (OTLK) 12/29/2016 4:17:10 PM Micro View Financials 10-K SEC Y 2016 ending: 9/30/2016 Rev: $2,979,576 -42.9% Assets $25,405,934 EPS -$3.67
Oncobiologics, Inc. (OTLK) 8/15/2016 5:09:36 PM Micro View Financials 10-Q SEC 3Q 2016 ending: 6/30/2016 Rev: $494,894 -61.8% Assets $32,992,325 EPS -$1.60
Oncobiologics, Inc. (OTLK) 6/27/2016 4:52:31 PM Micro View Financials 10-Q SEC 2Q 2016 ending: 3/31/2016 Rev: $994,894 +101.0% Assets $24,831,451 EPS -$0.32